0.5144
price down icon2.94%   -0.0156
after-market After Hours: .52 0.0056 +1.09%
loading
Can-Fite Biopharma Ltd ADR stock is traded at $0.5144, with a volume of 217.05K. It is down -2.94% in the last 24 hours and down -22.01% over the past month. Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and liver diseases, as well as sexual dysfunction. The company's lead drug candidate is CF101 (Piclidenoson), which is in Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis. It also develops CF102 (Namodenoson) that is in Phase II clinical trials for the treatment of liver cancer and non-alcoholic fatty liver diseases, as well as for hepatocellular carcinoma and hepatitis C virus diseases; and CF602, which is in pre-clinical trial for the treatment of sexual dysfunction. Can-Fite BioPharma Ltd. was founded in 1994 and is headquartered in Petah-Tikva, Israel.
See More
Previous Close:
$0.53
Open:
$0.52
24h Volume:
217.05K
Relative Volume:
0.99
Market Cap:
$792.90K
Revenue:
$743.00K
Net Income/Loss:
$-7.63M
P/E Ratio:
-0.1715
EPS:
-3
Net Cash Flow:
-
1W Performance:
-16.82%
1M Performance:
-22.01%
6M Performance:
-67.24%
1Y Performance:
-79.09%
1-Day Range:
Value
$0.5009
$0.52
1-Week Range:
Value
$0.5009
$0.6262
52-Week Range:
Value
$0.5009
$3.12

Can-Fite Biopharma Ltd ADR Stock (CANF) Company Profile

Name
Name
Can-Fite Biopharma Ltd ADR
Name
Phone
972 3 924 1114
Name
Address
10 Bareket Street, Kiryat Matalon PO Box 7537, Petah-Tikva
Name
Employee
7
Name
Twitter
@CanFitePharma
Name
Next Earnings Date
2024-12-31
Name
Latest SEC Filings
Name
CANF's Discussions on Twitter

Compare CANF with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CANF
Can-Fite Biopharma Ltd ADR
0.5144 9.05M 743.00K -7.63M 0 -3.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Can-Fite Biopharma Ltd ADR Stock (CANF) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-11-17 Initiated Maxim Group Buy
Oct-19-16 Resumed ROTH Capital Buy
Aug-29-16 Resumed Rodman & Renshaw Buy
Nov-30-15 Reiterated H.C. Wainwright Buy
Mar-31-15 Reiterated H.C. Wainwright Buy
Mar-30-15 Downgrade ROTH Capital Buy → Neutral
Dec-29-14 Reiterated ROTH Capital Buy
Nov-18-14 Initiated H.C. Wainwright Buy
View All

Can-Fite Biopharma Ltd ADR Stock (CANF) Latest News

pulisher
10:29 AM

Will Can Fite Biopharma Ltd Sponsored ADR stock beat growth indexesJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com

10:29 AM
pulisher
Oct 10, 2025

Why Can Fite Biopharma Ltd Sponsored ADR stock could outperform next yearGlobal Markets & Weekly Return Optimization Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Why pension funds invest in Can Fite Biopharma Ltd Sponsored ADR stockJuly 2025 Selloffs & Reliable Trade Execution Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Why Can Fite Biopharma Ltd Sponsored ADR stock fits value portfolios2025 Bull vs Bear & Smart Allocation Stock Reports - newser.com

Oct 09, 2025
pulisher
Oct 05, 2025

Is Can Fite Biopharma Ltd Sponsored ADR stock expanding market penetration2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com

Oct 05, 2025
pulisher
Oct 01, 2025

Is Can Fite Biopharma Ltd Sponsored ADR stock a contrarian opportunityEarnings Miss & Real-Time Volume Triggers - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

Why Can Fite Biopharma Ltd Sponsored ADR stock is a strong buy callEarnings Beat & High Accuracy Swing Entry Alerts - newser.com

Sep 30, 2025
pulisher
Sep 22, 2025

Analyzing recovery setups for Can Fite BioPharma Ltd. Depositary Receipt investorsJuly 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Institutional scanner results for Can Fite BioPharma Ltd. Depositary ReceiptMarket Performance Recap & Smart Money Movement Alerts - newser.com

Sep 22, 2025
pulisher
Sep 17, 2025

Developing predictive dashboards with CISS dataTreasury Yields & Technical Analysis for Trade Confirmation - newser.com

Sep 17, 2025
pulisher
Sep 17, 2025

Is a relief rally coming for Inovio Pharmaceuticals Inc. holders2025 Technical Overview & Risk Controlled Swing Trade Alerts - newser.com

Sep 17, 2025
pulisher
Sep 16, 2025

Smart tools for monitoring Can Fite BioPharma Ltd. Depositary Receipt’s price action2025 Market Overview & Precise Buy Zone Tips - newser.com

Sep 16, 2025
pulisher
Sep 14, 2025

Order flow analysis tools used on BOOMWatch List & Accurate Technical Buy Alerts - newser.com

Sep 14, 2025
pulisher
Sep 03, 2025

Can-Fite BioPharma (NYSE:CANF) Given Buy Rating at D. Boral Capital - Defense World

Sep 03, 2025
pulisher
Sep 02, 2025

Can swing trading help recover from Crane NXT Co. lossesMarket Growth Summary & AI Optimized Trade Strategies - Newser

Sep 02, 2025
pulisher
Aug 30, 2025

Has FVRR formed a bullish divergence2025 Key Lessons & Low Risk High Win Rate Picks - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Applying sector rotation models to Vale S.A. Depositary ReceiptJuly 2025 Catalysts & Reliable Price Action Trade Plans - Newser

Aug 29, 2025
pulisher
Aug 28, 2025

Sentiment analysis tools applied to Vertical Aerospace Ltd.2025 Dividend Review & Weekly Setup with ROI Potential - Newser

Aug 28, 2025
pulisher
Aug 27, 2025

Using RSI to spot recovery in ALDFUJuly 2025 Market Mood & Precise Swing Trade Entry Alerts - Newser

Aug 27, 2025

Can-Fite Biopharma Ltd ADR Stock (CANF) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):